Moderna shares are trading lower after The Patent Trial and Appeals Board turned down the company’s appeal to invalidate two of Arbutus’ patents on drug-delivery technology. The stock has been volatile amid COVID-19 omicron variant concerns.

by | Dec 1, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.